摘要:
The present invention relates to the development of a biosensor to determine potassium in human blood serum using dibenzo-18-crown-6 (DB18C6) as ionophore. Human blood serum contains potassium in ppm levels i.e. 137 to 200 mg/litre and sodium co exists with a 30 times higher concentration. Such a high concentration tends to interfere the selectivity towards potassium, but DB18C6 proves to have an excellent selectivity towards potassium and is highly sensitive to the lowest concentration of potassium levels present in the human blood serum. So the present invention reports the fabrication and characterization of ISFET (Ion Selective Field Effect transistor) coated with a monolayer of crown ether, dissolved in chloroform, on the gate of electrode.
摘要:
The present invention relates to the development of a biosensor to determine potassium in human blood serum using dibenzo-18-crown-6 (DB18C6) as ionophore. Human blood serum contains potassium in ppm levels i.e 137 to 200 mg/litre and sodium co exists with a 30 times higher concentration. Such a high concentration tends to interfere the selectivity towards potassium, but DB18C6 proves to have an excellent selectivity towards potassium and is highly sensitive to the lowest concentration of potassium levels present in the human blood serum. So the present invention reports the fabrication and characterization of ISFET (Ion Selective Field Effect transistor) coated with a monolayer of crown ether, dissolved in chloroform, on the gate of electrode.
摘要:
The present invention provides a novel sensor for the estimation of total cholesterol in human blood serum using molecular imprint of cholesterol. Human blood serum contains 150-250 mg/dl cholesterol. The present invention provides a sensor device and a process for the fabrication of ISFET (Ion Selective Field Effect Transister) coated with molecular imprint of cholesterol on the SiO2+Si3N4 dielectric gate of the said electrode. The molecular imprint of cholesterol (MIPC) anchored in to a silica matrix sensing material is identified as a sensing material which has specific selectivity towards the cholesterol in presence of other organic constituents in human blood serum.
摘要翻译:本发明提供了一种用于使用胆固醇分子印记估计人血清中总胆固醇的新型传感器。 人血清含有150-250 mg / dl胆固醇。 本发明提供一种用于制造在所述电极的SiO 2 + Si 3 N 4电介质栅极上涂覆有胆固醇分子印迹的ISFET(离子选择性场效应转移)的传感器装置和方法。 锚定在二氧化硅基质感测材料中的胆固醇(MIPC)的分子印记被鉴定为在人血清中存在其它有机成分时对胆固醇具有特异性选择性的感测材料。
摘要:
The present invention provides a novel sensor for the estimation of total cholesterol in human blood serum using molecular imprint of cholesterol. Human blood serum contains 150-250 mg/dl cholesterol. The present invention provides a sensor device and a process for the fabrication of ISFET (Ion Selective Field Effect Transister) coated with molecular imprint of cholesterol on the SiO2+Si3N4 dielectric gate of the said electrode. The molecular imprint of cholesterol (MIPC) anchored in to a silica matrix sensing material is identified as a sensing material which has specific selectivity towards the cholesterol in presence of other organic constituents in human blood serum.
摘要翻译:本发明提供了一种用于使用胆固醇分子印记估计人血清中总胆固醇的新型传感器。 人血清含有150-250 mg / dl胆固醇。 本发明提供一种用于制造在所述电极的SiO 2 + Si 3 N 4电介质栅极上涂覆有胆固醇分子印迹的ISFET(离子选择性场效应转移)的传感器装置和方法。 锚定在二氧化硅基质感测材料中的胆固醇(MIPC)的分子印记被鉴定为在人血清中存在其它有机成分时对胆固醇具有特异性选择性的感测材料。